PUBLISHER: IMARC | PRODUCT CODE: 2016749
PUBLISHER: IMARC | PRODUCT CODE: 2016749
Diabetic Retinopathy Market Size, Share, Trends and Forecast by Type, Treatment Type, End-User, and Region, 2026-2034
The global diabetic retinopathy market size was valued at USD 8.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 13.6 Billion by 2034, exhibiting a CAGR of 4.63% during 2026-2034. North America currently dominates the market, holding a significant market share of over 43.8% in 2025, owing to its high diabetes prevalence, advanced healthcare infrastructure, and early adoption of innovative diagnostics and anti-VEGF therapies. Supportive reimbursement policies and strong R&D investment further strengthen the region's dominance in the diabetic retinopathy market share.
Diabetic retinopathy (DR) is a common complication of diabetes that affects the retina, the part of the eye that senses light and sends signals to the brain. It occurs when high blood sugar levels damage the small blood vessels in the retina, causing them to leak or become blocked. This can lead to vision loss or blindness if left untreated. There are two main types of diabetic retinopathy, namely non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Its diagnosis involves a comprehensive eye exam, which may include tests such as fluorescein angiography and optical coherence tomography. These tests can help to identify the presence and severity of DR, allowing for early intervention and treatment. Currently, there are several treatment options available for DR, including the use of intraocular steroid injections, laser treatment, and vitrectomy. Intraocular steroid injections can help to reduce inflammation and swelling in the eye, while laser treatment can be used to seal leaking blood vessels and prevent further damage to the retina. In more severe cases, a vitrectomy may be necessary to remove blood or scar tissue from the eye.
Diabetic Retinopathy Market Trends:
The global diabetic retinopathy market is witnessing significant growth, primarily driven by the rising prevalence of diabetes and the increasing geriatric population. In line with this, key players are actively working to develop new therapeutic solutions for diabetic retinopathy, which is bolstering market growth. Apart from this, the development of new drugs and therapies, such as anti-VEGF agents and sustained-release implants, has also significantly contributed to market growth. Additionally, the escalating adoption of telemedicine and artificial intelligence (AI) in the diagnosis and treatment of diabetic retinopathy is driving the market growth. The rising demand for effective treatments due to the growing awareness of diabetic retinopathy and its potential consequences is acting as another growth-inducing factor. Furthermore, the surging awareness regarding early diagnosis and treatment of diabetic retinopathy, coupled with advancements in ophthalmic technology, are fueling the market growth. Other factors, such as increasing healthcare expenditure, the implementation of various government initiatives to improve eye care services, and the availability of favorable reimbursement policies, are propelling the market growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global diabetic retinopathy market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on type, treatment type and end-user.
Type Insights:
- Proliferative Diabetic Retinopathy
- Non-proliferative Retinopathy
Treatment Type Insights:
- Anti VEGF Drugs
- Steroid Implants
- Laser Surgeries
- Vitrectomy
End-User Insights:
- Hospitals and Pharmacies
- Eye Clinics
- Ambulatory Surgical Centres (ASCs)
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America dominates the market. Some of the factors accelerating the North America diabetic retinopathy market include the increasing prevalence of diabetes, growing awareness about diabetic retinopathy, and advancements in diagnostic and treatment technologies.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global diabetic retinopathy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global diabetic retinopathy market performed so far, and how will it perform in the coming years ?
- What are the drivers, restraints, and opportunities in the global diabetic retinopathy market ?
- What is the impact of each driver, restraint, and opportunity on the global diabetic retinopathy market ?
- What are the key regional markets ?
- Which countries represent the most attractive diabetic retinopathy market ?
- What is the breakup of the market based on the type ?
- Which is the most attractive type in the diabetic retinopathy market ?
- What is the breakup of the market based on the treatment type ?
- Which is the most attractive treatment type in the diabetic retinopathy market ?
- What is the breakup of the market based on the end-user ?
- Which is the most attractive end-user in the diabetic retinopathy market ?
- What is the competitive structure of the global diabetic retinopathy market ?
- Who are the key players/companies in the global diabetic retinopathy market ?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Diabetic Retinopathy Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Proliferative Diabetic Retinopathy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Non-proliferative Retinopathy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Treatment Type
- 7.1 Anti VEGF Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Steroid Implants
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Laser Surgeries
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Vitrectomy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End-User
- 8.1 Hospitals and Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Eye Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centres (ASCs)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Alimera Sciences
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.2 Allergan Plc
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Ampio Pharmaceuticals
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.4 Bayer Healthcare
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 BCN Peptides
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Genentech
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 SWOT Analysis
- 13.3.7 Kowa Group
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.8 Novartis AG
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 Regeneron Pharmaceuticals Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Sirnaomics Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.1 Alimera Sciences
List of Figures
- Figure 1: Global: Diabetic Retinopathy Market: Sales Value (in Billion USD), 2020-2025
- Figure 2: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2025
- Figure 3: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2025
- Figure 4: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2025
- Figure 5: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2025
- Figure 6: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion USD), 2026-2034
- Figure 7: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 9: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 11: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 13: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 15: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 17: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 19: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 21: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 23: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 25: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 26: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 27: North America: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 28: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 29: United States: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 30: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 31: Canada: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 32: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 33: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 34: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 35: China: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 36: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 37: Japan: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 38: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 39: India: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 40: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 41: South Korea: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 42: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 43: Australia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 44: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 45: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 46: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 47: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 48: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 49: Europe: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 50: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 51: Germany: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 52: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 53: France: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 54: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 55: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 56: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 57: Italy: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 58: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 59: Spain: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 60: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 61: Russia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 62: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 63: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 64: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 65: Latin America: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 66: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 67: Brazil: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 68: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 69: Mexico: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 70: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 71: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 72: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 73: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million USD), 2020 & 2025
- Figure 74: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 75: Global: Diabetic Retinopathy Industry: SWOT Analysis
- Figure 76: Global: Diabetic Retinopathy Industry: Value Chain Analysis
- Figure 77: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2025 and 2034
- Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million USD), 2026-2034
- Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million USD), 2026-2034
- Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million USD), 2026-2034
- Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million USD), 2026-2034
- Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
- Table 7: Global: Diabetic Retinopathy Market: Key Players
